Pathophysiology of ischemic nephropathy

Urologic Clinics of North America

Volumn 28, Issue 4, 2001, Pages 793-803

  Lerman, L ^a   Textor, S C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN; NITRIC OXIDE;

BLOOD PRESSURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY PERFUSION; MAGNETIC RESONANCE ANGIOGRAPHY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE INJURY;

EID: 0035668599     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(01)80034-3     Document Type: Article

References (72)

1. Diagnosing vascular causes of renal failure
2. The role of basally synthesized nitric oxide in modulating the renal vasoconstrictor action of angiotensin II
3. Nitric oxide in the kidney: Synthesis, localization and function
4. Extracellular matrix-related genes in kidney after ischemic injury: Potential role for TGF beta in repair
5. Involvement of reactive oxygen species in kidney damage
6. Apoptosis: Basic concepts and implications in coronary artery disease
7. Bile acids, oxidative stress and renal function in biliary obstruction
8. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis
9. Renal artery reconstruction for the preservation of renal function
10. Prospective study of atherosclerotic disease progression in the renal artery
11. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis
12. Alterations in rabbit renal microvascular prostanoid synthesis in acute renal failure
13. Reactive oxygen metabolite scavengers decrease functional coronary microvascular injury due to ischemia-reperfusion
14. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries
15. Sequential renal hemodynamics in experimental benign and malignant hypertension
16. Molecular insights into renal interstitial fibrosis
17. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression
18. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
19. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion
20. Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR
21. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy
22. Role of transforming growth factor-beta in tissue injury and repair
23. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy
24. Control of glomerular filtration rate by renin-angiotensin system
25. Advanced renovascular hypertension and renal insufficiency: Trends in medical comorbidity and surgical approach from 1970 to 1993
26. Surgical management of dialysis-dependent ischemic nephropathy
27. Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization
28. Endothelin in ischemic acute renal failure
29. Angiotensin II induces superoxide anion production by mesangial cells
30. Cellular and metabolic consequences of chronic ischemia on kidney function
31. Role of AT1 angiotensin II receptors in renal ischemic injury
32. Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithehal cells
33. Pressure dependency of canine intrarenal blood flow within the range of autoregulation
34. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension
35. Beta-1 integrin-mediated adhesion between renal tubular cells after anoxic injury
36. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats
37. Angiotensin in progressive renal diseases: Theory and practice
38. Critical arterial stenosis
39. Ischemic renal diseases: New insights into old entities
40. The role of cell adhesion molecules in ischemic acute renal failure
41. Morphological changes and alterations in regional intrarenal blood flow induced by graded renal ischemia
42. Role for NADPH/NADH oxidase in the modulation of vascular tone
43. Endothelium-derived vasoactive factors in hypertension: Nitric oxide and endothelin
44. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes
45. Renal vein oxygen saturation in renal artery stenosis
46. Patient selection for intervention to preserve renal function in ischemic renal disease
47. Prevalence of atherosclerotic RAS in patients with atherosclerosis elsewhere
48. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits
49. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
50. Nitric oxide in hypertension: Relationship with renal injury and left ventricular hypertrophy
51. Pathophysiology of progressive nephropathies
52. Influence of hypoxia on hepatic and renal endothelin gene expression
53. Role of angiotensin and oxidative stress in essential hypertension
54. Renal prostaglandin synthesis: Sites of production and specific actions of prostaglandins
55. Atherosclerotic renovascular disease: Remediable cause of renal failure in the elderly
56. Renal nitric oxide and angiotensin II interaction in renovascular hypertension
57. Ischemic renal diseases have become the most frequent causes of end-stage renal disease in the elderly
58. Endothelin-1 enhances vascular permeability in conscious rats: Role of thromboxane A2
59. Mechanisms of cellular injury in ischemic acute renal failure
60. Renal parenchymal disease and hypertension
61. Revascularization in atherosclerotic renal artery disease
62. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease
63. Renal failure limiting antihypertensive therapy as an indication for renal revascularization
64. Poststenotic arterial pressure, renal haemodynamics and sodium excretion during graded pressure reduction in conscious rats with one- and two-kidney coarctation hypertension
65. Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia
66. Experimental chronic renal ischemia: Morphologic and immunologic studies
67. Plasma erythropoietin concentration in renal venous blood of patients with unilateral renovascular hypertension
68. Renal ischaemiareperfusion injury
69. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta
70. Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury
71. Collateral circulation to an ischemic kidney
72. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats